Zhuhai Sailong Pharmaceutical (002898)

Zhuhai Sailong Pharmaceutical (002898)

$ 10

Trading Risk Analysis

English Version

Date : 1 Mar 2021


ZHUHAI SAILONG PHARMACEUTICAL CO LTD is a China-based company principally engaged in the research and development, production and sales of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and preparations, as well as providing technical services. The Company’s main products include monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others. Through its subsidiaries, the Company is also engaged in the sales of scraps, provision of technical services and sales promotion. The Company mainly conducts its businesses with domestic market.


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

Close Bitnami banner